Empowering innovation at Windlas Biotech where advanced research meets sustainable solutions. Driven by science, we are dedicated to transforming health through pioneering biotech advancements and excellence in research and development.

Company (Headquarters):

India

Types of Drugs Manufactured:

Nutraceuticals

CDMO Services:

Drug Product/FDF;Research & Development;Packaging(Commercial);Regulatory Services;Analytical Development;Process & Forumulation Development;Supply Chain Logistics

Therapeutic Area:

Cardiovascular;Central Nervous System;Ear Nose Throat and Oral health;Gastrointestinal and Metabolism;Genito Urinary and Women’s Health;Hematology;Immunology;Infectious Disease;Musculoskeletal System;Nutritional;Ophthalmology;Wounds and Injuries;Pain Symptoms

CDMO Number of Facilities:

6

High Potent Products capabilities:

OEB 3 Medium Potency

Facilities Location:

South Asia

Regulatory Approvals for facilities:

Europe – EMA or constituent countries;India – CDSCO;WHO

Manufacturing Technologies:

Lyophilized amps/vials;Oral Liquids;Sterile Ampoules;Sterile Vials;Tablets/Capsules

Current Capacity:

With end-to-end CDMO capabilities—from development and validation to commercial manufacturing—and experience serving over 100 pharmaceutical partners globally, Windlas Biotech is well-equipped to take on new partnerships across a wide range of dosage forms and therapeutic segments.